TR200200014T2 - Nörotik düzensizliklerin tedavisi. - Google Patents
Nörotik düzensizliklerin tedavisi.Info
- Publication number
- TR200200014T2 TR200200014T2 TR2002/00014T TR200200014T TR200200014T2 TR 200200014 T2 TR200200014 T2 TR 200200014T2 TR 2002/00014 T TR2002/00014 T TR 2002/00014T TR 200200014 T TR200200014 T TR 200200014T TR 200200014 T2 TR200200014 T2 TR 200200014T2
- Authority
- TR
- Turkey
- Prior art keywords
- disorder
- treatment
- angleness
- neurotic
- neurotic disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
Eskitalopramin (sitalopramin S-(+)-enantiomeri) ya da bunun farmasötik olarak kabul edilebilir bir tuzunun aralarinda angziyete durumlari, özellikle genellestirilmis angziyete düzensizligi ve sosyal angziyete düzensizligi, travma sonrasi stres düzensizligi, obsesif kompülsif düzensizlik ve panik ataklarin bulundugu nörotik düzensizliklerin tedavisinde kullanisli bir ilacin hazirlanmasi için kullanimi.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199900991 | 1999-07-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200200014T2 true TR200200014T2 (tr) | 2002-05-21 |
Family
ID=8099796
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2004/02276T TR200402276T2 (tr) | 1999-07-08 | 2000-07-07 | Nörotik düzensizliklerin tedavisi |
TR2002/00014T TR200200014T2 (tr) | 1999-07-08 | 2000-07-07 | Nörotik düzensizliklerin tedavisi. |
TR2004/02277T TR200402277T2 (tr) | 1999-07-08 | 2000-07-07 | Nörotik düzensizliklerin tedavisi |
TR2004/02275T TR200402275T2 (tr) | 1999-07-08 | 2000-07-07 | Nörotik düzensizliklerin tedavisi |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2004/02276T TR200402276T2 (tr) | 1999-07-08 | 2000-07-07 | Nörotik düzensizliklerin tedavisi |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2004/02277T TR200402277T2 (tr) | 1999-07-08 | 2000-07-07 | Nörotik düzensizliklerin tedavisi |
TR2004/02275T TR200402275T2 (tr) | 1999-07-08 | 2000-07-07 | Nörotik düzensizliklerin tedavisi |
Country Status (38)
Country | Link |
---|---|
US (6) | US7271194B2 (tr) |
EP (4) | EP1440691A3 (tr) |
JP (1) | JP4773011B2 (tr) |
KR (1) | KR100604176B1 (tr) |
CN (1) | CN1198610C (tr) |
AR (1) | AR021155A1 (tr) |
AT (1) | ATE339955T1 (tr) |
AU (6) | AU782514B2 (tr) |
BG (4) | BG110466A (tr) |
BR (1) | BR0011578A (tr) |
CA (4) | CA2687392A1 (tr) |
CL (3) | CL2008003941A1 (tr) |
CO (1) | CO5190674A1 (tr) |
CY (1) | CY1105806T1 (tr) |
CZ (1) | CZ200270A3 (tr) |
DE (1) | DE60030861T2 (tr) |
DK (1) | DK1200081T3 (tr) |
EA (1) | EA006555B1 (tr) |
ES (1) | ES2272298T3 (tr) |
HK (1) | HK1048069B (tr) |
HR (1) | HRP20010820A2 (tr) |
HU (1) | HUP0201791A3 (tr) |
IL (5) | IL146131A0 (tr) |
IS (1) | IS6137A (tr) |
ME (2) | ME00032B (tr) |
MX (1) | MXPA01011626A (tr) |
MY (1) | MY143278A (tr) |
NO (4) | NO329021B1 (tr) |
PL (1) | PL352030A1 (tr) |
PT (1) | PT1200081E (tr) |
SI (1) | SI1200081T1 (tr) |
SK (1) | SK82002A3 (tr) |
TR (4) | TR200402276T2 (tr) |
TW (1) | TWI232101B (tr) |
UA (1) | UA77645C2 (tr) |
WO (1) | WO2001003694A1 (tr) |
YU (1) | YU78701A (tr) |
ZA (1) | ZA200108856B (tr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR021155A1 (es) | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
GB0005477D0 (en) | 2000-03-07 | 2000-04-26 | Resolution Chemicals Limited | Process for the preparation of citalopram |
BR0113011A (pt) | 2000-07-21 | 2003-07-01 | Lundbeck & Co As H | Novos compostos e sua utilização como inibidores de transporte de glicina; composição farmacêutica e método do tratamento |
SK14612003A3 (sk) * | 2001-05-01 | 2004-04-06 | H. Lundbeck A/S | Použitie enantiomérne čistého escitalopramu a farmaceutický prostriedok s obsahom escitalopramu |
EP1522539B1 (en) | 2001-07-31 | 2007-01-24 | H. Lundbeck A/S | Crystalline composition containing escitalopram |
AU2003237524A1 (en) * | 2002-07-08 | 2004-01-23 | University Of Florida | Use of ssri inhibitors to prevent or ameliorate trauma-related psychological disorders |
US20050137255A1 (en) * | 2002-12-23 | 2005-06-23 | H. Lundbeck A/S | Crystalline escitalopram hydrobromide and methods for preparing the same |
CA2511142A1 (en) * | 2002-12-23 | 2004-07-08 | H. Lundbeck A/S | Escitalopram hydrobromide and a method for the preparation thereof |
AU2003223105A1 (en) * | 2003-03-24 | 2004-10-18 | Hetero Drugs Limited | Novel crystalline forms of (s)-citalopram oxalate |
US20090093461A1 (en) * | 2003-07-02 | 2009-04-09 | Astrazeneca Ab | Methods of Treating Anxiety and Mood Disorders |
EP1708790B1 (en) * | 2003-12-02 | 2010-04-21 | PharmaNeuroBoost N.V. | Use of pipamperone and a d2-receptor antagonist or a serotonin/dopamin antagonist for the treatment of psychotic disorders |
US7855195B2 (en) * | 2003-12-02 | 2010-12-21 | Pharmaneuroboost N.V. | Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
US7884096B2 (en) * | 2003-12-02 | 2011-02-08 | Pharmaneuroboost N.V. | Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
EP1954257A4 (en) | 2005-10-14 | 2009-05-20 | Lundbeck & Co As H | METHOD FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM WITH A LOW-DOSED COMBINATION OF ESCITALOPRAM AND BUPROPION |
US20070134322A1 (en) * | 2005-12-14 | 2007-06-14 | Forest Laboratories, Inc. | Modified and pulsatile release pharmaceutical formulations of escitalopram |
FR2912057B1 (fr) * | 2007-02-07 | 2009-04-17 | Sanofi Aventis Sa | Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine |
TW200817003A (en) * | 2006-07-31 | 2008-04-16 | Sanofi Aventis | Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1143703A (tr) * | 1965-03-18 | |||
GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
US4439545A (en) | 1981-11-19 | 1984-03-27 | Societe D "Expansion Scientifique "Expansia" | Acrylic copolymers of N-acryloylpolymethyleneimines or N-acryloyldialkylamides, N,N'-acryloyldiaminoalcanes and N-acryloylaminoacids (or esters) their preparation and use as cation exchangers |
GB8419963D0 (en) * | 1984-08-06 | 1984-09-12 | Lundbeck & Co As H | Intermediate compound and method |
GB8607313D0 (en) * | 1986-03-25 | 1986-04-30 | Ici Plc | Pharmaceutical compositions |
GB8814057D0 (en) * | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
US4902710A (en) * | 1988-12-14 | 1990-02-20 | Eli Lilly And Company | Serotonin and norepinephrine uptake inhibitors |
US5114976A (en) * | 1989-01-06 | 1992-05-19 | Norden Michael J | Method for treating certain psychiatric disorders and certain psychiatric symptoms |
US4962128A (en) * | 1989-11-02 | 1990-10-09 | Pfizer Inc. | Method of treating anxiety-related disorders using sertraline |
US5296507A (en) * | 1990-09-06 | 1994-03-22 | H.Lundbeck A/S | Treatment of cerbrovascular disorders |
DK213290D0 (da) | 1990-09-06 | 1990-09-06 | Lundbeck & Co As H | Treatment of cerebrovascular disorders |
US5708035A (en) * | 1991-02-04 | 1998-01-13 | Sepracor Inc. | Methods of use and compositions of R(-) fluoxetine |
WO1992018005A1 (en) | 1991-04-16 | 1992-10-29 | National Institutes Of Health | Method of treating trichotillomania and onychophagia |
ATE244563T1 (de) | 1991-11-15 | 2003-07-15 | Sepracor Inc | Verwendung von reinem fluoxetin-s(+)-isomer für die herstellung eines medikements gegen migräne |
EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug responses by serotonin 1A receptor antagonists |
US5627196A (en) * | 1995-01-17 | 1997-05-06 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
AU4918796A (en) * | 1995-02-10 | 1996-08-27 | Eli Lilly And Company | Methods of treating or preventing psychiatric disorders |
US5554383A (en) * | 1995-04-06 | 1996-09-10 | Trustees Of Tufts College | Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression |
SE9501567D0 (sv) * | 1995-04-27 | 1995-04-27 | Astra Ab | A new combination |
ES2145977T3 (es) | 1995-08-16 | 2000-07-16 | Lilly Co Eli | Potenciacion de la respuesta de la serotonina. |
US5846982A (en) * | 1996-06-14 | 1998-12-08 | Eli Lilly And Company | Inhibition of serotonin reuptake |
US5912256A (en) * | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
US5747494A (en) * | 1996-06-28 | 1998-05-05 | U C B S.A. | Pharmaceutical compositions for the treatment of depressive disorders |
US5958429A (en) * | 1996-08-16 | 1999-09-28 | Eli Lilly And Company | Potentiation of serotonin response |
ZA977967B (en) * | 1996-09-23 | 1999-03-04 | Lilly Co Eli | Combination therapy for treatment of psychoses |
US5776969A (en) * | 1997-02-27 | 1998-07-07 | Eli Lilly And Company | Treatment of sleep disorders |
US6069177A (en) * | 1997-07-08 | 2000-05-30 | The Hong Kong University Of Science And Technology | 3-Hydroxy-propanamine derived neuronal reuptake inhibitors |
SE9703375D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | A new combination |
SE9703379D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
CA2291072C (en) * | 1997-11-11 | 2002-08-20 | H. Lundbeck A/S | Method for the preparation of citalopram |
DK0957099T3 (da) * | 1998-04-15 | 2003-03-17 | Pfizer Prod Inc | Heterocykliske carboxamider |
AU4850199A (en) * | 1998-06-30 | 2000-01-17 | Eli Lilly And Company | Pyrrolidine and pyrroline derivatives having effects on serotonin related systems |
DE69935331T2 (de) | 1998-07-13 | 2007-10-31 | NPS Pharmaceuticals, Inc., Salt Lake City | Verfahren und verbindungen zur behandlung der depression |
US6579899B1 (en) | 1998-07-16 | 2003-06-17 | Massachusetts Institute Of Technology | Composition for treatment of stress |
EP1096927A4 (en) | 1998-07-16 | 2002-09-04 | Massachusetts Inst Technology | STRESS TREATMENT COMPOSITION |
US6150376A (en) * | 1998-08-05 | 2000-11-21 | Georgetown University | Bi- and tri-cyclic aza compounds and their uses |
SE9803158D0 (sv) * | 1998-09-16 | 1998-09-16 | Astra Ab | A new composition |
SE9803157D0 (sv) | 1998-09-16 | 1998-09-16 | Astra Ab | A new composition |
HU228576B1 (en) * | 1998-10-20 | 2013-04-29 | Lundbeck & Co As H | Method for the preparation of citalopram |
AR021509A1 (es) * | 1998-12-08 | 2002-07-24 | Lundbeck & Co As H | Derivados de benzofurano, su preparacion y uso |
ATE237604T1 (de) * | 1999-04-14 | 2003-05-15 | Lundbeck & Co As H | Verfahren zur herstellung von citalopram |
AR021155A1 (es) | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
US6333357B1 (en) * | 1999-11-05 | 2001-12-25 | Be Able, Llc | Behavior chemotherapy |
UA77650C2 (en) * | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
GB2357762B (en) * | 2000-03-13 | 2002-01-30 | Lundbeck & Co As H | Crystalline base of citalopram |
AU5565401A (en) * | 2000-04-24 | 2001-11-07 | Aryx Therapeutics | Materials and methods for the treatment of depression |
JP2002361405A (ja) * | 2000-09-25 | 2002-12-18 | Showa Denko Kk | 熱交換器の製造方法 |
SK14612003A3 (sk) * | 2001-05-01 | 2004-04-06 | H. Lundbeck A/S | Použitie enantiomérne čistého escitalopramu a farmaceutický prostriedok s obsahom escitalopramu |
-
2000
- 2000-07-06 AR ARP000103442A patent/AR021155A1/es unknown
- 2000-07-07 CO CO00051031A patent/CO5190674A1/es not_active Application Discontinuation
- 2000-07-07 BR BR0011578-9A patent/BR0011578A/pt active Search and Examination
- 2000-07-07 YU YU78701A patent/YU78701A/sh unknown
- 2000-07-07 EP EP04007522A patent/EP1440691A3/en not_active Withdrawn
- 2000-07-07 EP EP04007520A patent/EP1440689A3/en not_active Withdrawn
- 2000-07-07 DE DE60030861T patent/DE60030861T2/de not_active Expired - Lifetime
- 2000-07-07 PL PL00352030A patent/PL352030A1/xx not_active Application Discontinuation
- 2000-07-07 SI SI200030910T patent/SI1200081T1/sl unknown
- 2000-07-07 AU AU58061/00A patent/AU782514B2/en not_active Expired
- 2000-07-07 CA CA2687392A patent/CA2687392A1/en not_active Abandoned
- 2000-07-07 ME MEP-2008-25A patent/ME00032B/me unknown
- 2000-07-07 JP JP2001508974A patent/JP4773011B2/ja not_active Expired - Lifetime
- 2000-07-07 KR KR1020017016006A patent/KR100604176B1/ko not_active IP Right Cessation
- 2000-07-07 TR TR2004/02276T patent/TR200402276T2/tr unknown
- 2000-07-07 EA EA200200137A patent/EA006555B1/ru not_active IP Right Cessation
- 2000-07-07 TR TR2002/00014T patent/TR200200014T2/tr unknown
- 2000-07-07 CZ CZ200270A patent/CZ200270A3/cs unknown
- 2000-07-07 PT PT00943692T patent/PT1200081E/pt unknown
- 2000-07-07 TR TR2004/02277T patent/TR200402277T2/tr unknown
- 2000-07-07 ES ES00943692T patent/ES2272298T3/es not_active Expired - Lifetime
- 2000-07-07 ME MEP-25/08A patent/MEP2508A/xx unknown
- 2000-07-07 MX MXPA01011626A patent/MXPA01011626A/es not_active Application Discontinuation
- 2000-07-07 TR TR2004/02275T patent/TR200402275T2/tr unknown
- 2000-07-07 MY MYPI20003122A patent/MY143278A/en unknown
- 2000-07-07 AT AT00943692T patent/ATE339955T1/de active
- 2000-07-07 CA CA002373757A patent/CA2373757C/en not_active Expired - Lifetime
- 2000-07-07 IL IL14613100A patent/IL146131A0/xx unknown
- 2000-07-07 UA UA2001128286A patent/UA77645C2/uk unknown
- 2000-07-07 HU HU0201791A patent/HUP0201791A3/hu unknown
- 2000-07-07 EP EP00943692A patent/EP1200081B1/en not_active Revoked
- 2000-07-07 SK SK8-2002A patent/SK82002A3/sk not_active Application Discontinuation
- 2000-07-07 CA CA2687394A patent/CA2687394A1/en not_active Abandoned
- 2000-07-07 CA CA2687396A patent/CA2687396A1/en not_active Abandoned
- 2000-07-07 WO PCT/DK2000/000377 patent/WO2001003694A1/en active Application Filing
- 2000-07-07 EP EP04007521A patent/EP1440690A3/en not_active Withdrawn
- 2000-07-07 DK DK00943692T patent/DK1200081T3/da active
- 2000-07-07 CN CNB008100292A patent/CN1198610C/zh not_active Expired - Lifetime
- 2000-07-28 TW TW089115110A patent/TWI232101B/zh not_active IP Right Cessation
-
2001
- 2001-10-23 IL IL146131A patent/IL146131A/en active IP Right Grant
- 2001-10-26 ZA ZA200108856A patent/ZA200108856B/xx unknown
- 2001-10-30 IS IS6137A patent/IS6137A/is unknown
- 2001-11-06 HR HR20010820A patent/HRP20010820A2/hr not_active Application Discontinuation
- 2001-12-12 US US10/021,126 patent/US7271194B2/en not_active Expired - Lifetime
-
2002
- 2002-01-04 BG BG11046609A patent/BG110466A/bg unknown
- 2002-01-04 BG BG11046709A patent/BG110467A/bg unknown
- 2002-01-04 BG BG106279A patent/BG106279A/bg unknown
- 2002-01-04 BG BG11046809A patent/BG110468A/bg unknown
- 2002-01-07 NO NO20020062A patent/NO329021B1/no not_active IP Right Cessation
-
2003
- 2003-01-09 HK HK03100231.6A patent/HK1048069B/zh not_active IP Right Cessation
- 2003-08-07 US US10/637,822 patent/US20040029958A1/en not_active Abandoned
- 2003-08-07 US US10/637,821 patent/US20040029957A1/en not_active Abandoned
- 2003-08-07 US US10/637,820 patent/US7265151B2/en not_active Expired - Lifetime
- 2003-08-20 US US10/644,143 patent/US6960613B2/en not_active Expired - Lifetime
-
2005
- 2005-06-20 AU AU2005202686A patent/AU2005202686B2/en not_active Expired
- 2005-06-20 AU AU2005202685A patent/AU2005202685B2/en not_active Ceased
- 2005-06-20 AU AU2005202684A patent/AU2005202684B2/en not_active Ceased
- 2005-08-09 IL IL170192A patent/IL170192A/en unknown
- 2005-08-09 IL IL170193A patent/IL170193A/en unknown
- 2005-08-09 IL IL170194A patent/IL170194A/en unknown
-
2006
- 2006-11-27 CY CY20061101706T patent/CY1105806T1/el unknown
-
2007
- 2007-08-10 US US11/837,317 patent/US20070276035A1/en not_active Abandoned
-
2008
- 2008-12-24 AU AU2008264188A patent/AU2008264188A1/en not_active Withdrawn
- 2008-12-24 AU AU2008264182A patent/AU2008264182A1/en not_active Withdrawn
- 2008-12-30 CL CL2008003941A patent/CL2008003941A1/es unknown
- 2008-12-30 CL CL2008003938A patent/CL2008003938A1/es unknown
- 2008-12-30 CL CL2008003939A patent/CL2008003939A1/es unknown
-
2010
- 2010-03-10 NO NO20100334A patent/NO20100334L/no not_active Application Discontinuation
- 2010-03-10 NO NO20100335A patent/NO20100335L/no not_active Application Discontinuation
- 2010-03-10 NO NO20100333A patent/NO20100333L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200200014T2 (tr) | Nörotik düzensizliklerin tedavisi. | |
EA200601269A1 (ru) | Лекарственное средство, содержащее производные фенилпиперазина | |
WO2002053140A3 (en) | New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents | |
BR0111898A (pt) | Métodos de tratamento de doenças de proliferação celular, e de um distúrbio associado com a atividade de cinesina ksp, método de inibição da cinesina ksp, composto, método de triagem de moduladores da cinesina kps, e, método de triagem de compostos que se ligam à cinesina ksp | |
TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
DE60142473D1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
CY1106733T1 (el) | Αγωγη νευρολογικης δυσλειτουργιας περιλαμβανουσα σουλφαμικες φρουκτοπυρανοζες και ερυθροποιητινη | |
BR0008958A (pt) | Inibidores de reabsorção de monoamina para otratamento de distúrbios do snc | |
PL415000A1 (pl) | Zastosowanie 40-O-(2-hydroksyetylo)-rapamycyny do wytwarzania leku do leczenia litych guzów ośrodkowego układu nerwowego | |
TR200000755T2 (tr) | Karşıt olma-karşı gelme bozukluğunun tedavisi. | |
NO20063308L (no) | Kombinasjon av flupirtin og tramadol | |
ATE422498T1 (de) | Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems | |
BR0210650A (pt) | Tablete, e, uso do mesmo | |
SE0102147D0 (sv) | New methods | |
PT966285E (pt) | Utilizacao de (+)mefloquina para o tratamento da malaria | |
HUP0402619A2 (hu) | Norepinefrin re-uptake inhibitorok alkalmazása a megértési nehézségek kezelésére használható gyógyszer előállítására | |
EE200100553A (et) | Saredutandi ja selle farmatseutiliselt vastuvõetavate soolade kasutamine meeleoluhäirete, kohanemishäirete või segatüüpi ärev-depressiivsete häirete raviks või vältimiseks kasulike ravimite valmistamiseks | |
BG108452A (en) | Tablet comprising cetirizine and pseudoephedrine | |
BR0015938A (pt) | Uso de antagonistas beta-adrenoceptores para a fabricação de um medicamento para o tratamento de desordens da retina externa | |
BR0316451A (pt) | Combinação sinergìstica compreendendo roflumilast e formoterol | |
BR0115881A (pt) | Emprego de compostos ciclohexanona substituìdos de 6-dimetilaminometil-1-fenil para a terapia da incontinência urinária | |
ATE241971T1 (de) | Kombinationspräparat zur behandlung von malaria | |
EA200001162A1 (ru) | Новые лекарственные комбинации ингибиторов повторного поглощения норадреналина (иппна), предпочтительно ребоксетина и пиндолола | |
TR200002970T2 (tr) | Sinir bozukluklarının yeni tedavileri | |
BR9807271A (pt) | Tamoxifeno como terapia para reduzir diarréia induzida por cloridrato de irinotecano |